Related Experiment Video
Updated: Mar 8, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers
Anthony Ferrari1, Anne-Sophie Sertier1, Anne Vincent-Salomon2
1Synergie Lyon Cancer, Plateforme de Bioinformatique 'Gilles Thomas' Centre Léon Bérard , Lyon, France.
Abstract:
Analysis of gene expression and whole-genome features of 64 human epidermal growth factor 2 (HER2)-positive breast tumors supports the idea that their intrinsic heterogeneity actually reflects their cell of origin, suggesting that HER2 amplification is an embedded event in the natural history of these tumors. Possible mechanisms for this event involve breakage-fusion-bridge and chromothripsis.
Related Concept Videos
Heritability
Mechanistic Models: Overview of Compartment Models
Principles of Pharmacogenetics: Types of Genetic Variants
Genetic Variation
Genes exist in different versions called alleles,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

